Header Logo

Connection

MARTIN KORBLING to Transplantation, Autologous

Back to Details
This is a "connection" page, showing publications MARTIN KORBLING has written about Transplantation, Autologous.
MARTIN KORBLING
Connection Strength
0.757
Transplantation, Autologous
  1. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. Am J Hematol. 2009 Jun; 84(6):335-7.
    View in: PubMed
    Score: 0.062
  2. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009 Jun; 15(6):718-23.
    View in: PubMed
    Score: 0.061
  3. Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transplant Proc. 1989 Feb; 21(1 Pt 3):3084-8.
    View in: PubMed
    Score: 0.060
  4. Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia. Bone Marrow Transplant. 2002 Jul; 30(1):15-22.
    View in: PubMed
    Score: 0.038
  5. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol. 2002 Mar; 13(3):450-9.
    View in: PubMed
    Score: 0.037
  6. Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation. Br J Haematol. 2001 Mar; 112(4):1012-5.
    View in: PubMed
    Score: 0.035
  7. Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2000 Dec; 26(12):1343-5.
    View in: PubMed
    Score: 0.034
  8. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer. 1997 Apr 15; 79(8):1617-22.
    View in: PubMed
    Score: 0.027
  9. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 12; 22(12):2159-2164.
    View in: PubMed
    Score: 0.026
  10. Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol. 1996 Jul; 94(1):155-8.
    View in: PubMed
    Score: 0.025
  11. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells. 1996 Mar; 14(2):185-95.
    View in: PubMed
    Score: 0.025
  12. Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation. Bone Marrow Transplant. 1994 May; 13(5):649-54.
    View in: PubMed
    Score: 0.022
  13. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission. Cancer. 2013 Sep 15; 119(18):3318-25.
    View in: PubMed
    Score: 0.020
  14. Some principles of blood stem cell transplantation. Transfus Sci. 1993 Jan; 14(1):61-4.
    View in: PubMed
    Score: 0.020
  15. Quality control in stem cell processing for autotransplantation. Transfus Sci. 1993 Jan; 14(1):101-4.
    View in: PubMed
    Score: 0.020
  16. Autologous blood stem cell versus bone marrow transplantation. Bone Marrow Transplant. 1992; 10 Suppl 1:144-8.
    View in: PubMed
    Score: 0.018
  17. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant. 1991 May; 7(5):343-9.
    View in: PubMed
    Score: 0.018
  18. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia. Haematologica. 1991 Mar; 76 Suppl 1:29-36.
    View in: PubMed
    Score: 0.017
  19. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood. 1990 Apr 15; 75(8):1606-14.
    View in: PubMed
    Score: 0.016
  20. Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma. Blood. 2009 Apr 30; 113(18):4144-52.
    View in: PubMed
    Score: 0.015
  21. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood. 1988 Aug; 72(2):672-8.
    View in: PubMed
    Score: 0.015
  22. Hyperfractionated total body irradiation as part of autologous bone marrow transplantation. Strahlenther Onkol. 1986 Apr; 162(4):246-7.
    View in: PubMed
    Score: 0.012
  23. [Autologous bone marrow transplantation in malignant lymphohematopoietic diseases]. Ter Arkh. 1986; 58(9):23-9.
    View in: PubMed
    Score: 0.012
  24. Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas. J Clin Oncol. 2005 Apr 01; 23(10):2240-7.
    View in: PubMed
    Score: 0.012
  25. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood. 1994 May 15; 83(10):3068-76.
    View in: PubMed
    Score: 0.011
  26. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy. Blut. 1984 Apr; 48(4):189-99.
    View in: PubMed
    Score: 0.011
  27. Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells. Blut. 1983 Feb; 46(2):89-93.
    View in: PubMed
    Score: 0.010
  28. 4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft. Br J Haematol. 1982 Sep; 52(1):89-96.
    View in: PubMed
    Score: 0.010
  29. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol. 1981 Jul; 9(6):684-90.
    View in: PubMed
    Score: 0.009
  30. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplant. 2000 Jun; 25(11):1115-9.
    View in: PubMed
    Score: 0.008
  31. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.
    View in: PubMed
    Score: 0.008
  32. Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 1999 Oct; 35(3-4):317-24.
    View in: PubMed
    Score: 0.008
  33. Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol. 1997 Feb; 15(2):667-73.
    View in: PubMed
    Score: 0.007
  34. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997 Jan; 19(2):121-7.
    View in: PubMed
    Score: 0.007
  35. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplant. 1991; 7 Suppl 1:13-7.
    View in: PubMed
    Score: 0.004
  36. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol. 1990 Jun; 8(6):978-85.
    View in: PubMed
    Score: 0.004
  37. Long-term disease-free survival following autologous bone marrow/blood stem cell transplantation in 89 patients with acute leukemia. Haematol Blood Transfus. 1990; 33:675-8.
    View in: PubMed
    Score: 0.004
  38. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2. Blood. 1989 Nov 01; 74(6):2270-7.
    View in: PubMed
    Score: 0.004
  39. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood. 1989 Nov 01; 74(6):1898-904.
    View in: PubMed
    Score: 0.004
  40. Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood. 1985 Jun; 65(6):1504-10.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.